Article
Short- and long-term clinical outcomes of nintedanib therapy in IPF patients with different phenotypes: A retrospective registry-based study.
Respiratory medicine - 1 Jan 2000
Koziar Vašáková Martina, Gregor Jakub, Mogulkoc Nesrin, Kramer Mordechai R, Lewandowska Katarzyna, Šterclová Martina, Müller Veronika, Slivka Róbert, Studnicka Michael, Plačková Martina, Žurková Monika, Tekavec-Trkanjec Jasna, Doubková Martina, Ovesná Petra
Abstract excerpt
BACKGROUND: There is a lack of data on the long-term effect of nintedanib on survival in specific groups of idiopathic pulmonary fibrosis (IPF) patients with different phenotypes. We investigated the outcomes of nintedanib therapy in an observational study of a large multicentre real-world cohort of IPF patients with various initial characteristics. METHODS: The analysis included IPF patients treated with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.